Carboxylic acid Leukotriene B4 antagonists

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

514513, 514543, 562462, 560 53, 560 54, 549401, A61K 3135, C07D31176

Patent

active

054571243

ABSTRACT:
The invention relates to compounds selected from the group consisting of the formulas: ##STR1## wherein R.sup.2 and Ph are as described herein. These compounds are potent leukotriene B.sub.4 antagonists and are therefore useful in the treatment of inflammatory diseases.

REFERENCES:
patent: 4281008 (1981-07-01), Chamberlain et al.
patent: 4499299 (1985-02-01), Bernstein et al.
patent: 4546194 (1985-10-01), Miyano et al.
patent: 4565882 (1986-01-01), Miyano et al.
patent: 4665203 (1987-05-01), Miyano et al.
patent: 4683325 (1987-07-01), Frenette et al.
patent: 4686235 (1987-08-01), Chang et al.
patent: 4841076 (1989-06-01), Kitagawa et al.
patent: 4889871 (1989-12-01), Djuric et al.
patent: 4935529 (1990-06-01), Yerwick
patent: 4950684 (1990-08-01), Koszyk et al.
patent: 4952705 (1990-08-01), Miyano et al.
patent: 5219883 (1993-06-01), Koszyk et al.
patent: 5273999 (1993-12-01), Cohen et al.
patent: 5310952 (1994-05-01), Heveling et al.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Carboxylic acid Leukotriene B4 antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Carboxylic acid Leukotriene B4 antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Carboxylic acid Leukotriene B4 antagonists will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2310674

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.